ArticleBMC anesthesiology2025
Efficacy of ultrasound localization and fiberoptic bronchoscopy-guided percutaneous dilatational tracheostomy in the intensive care unit.
Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Ultrasound-guided percutaneous dilatational tracheostomy versus landmark- and bronchoscopy-guided techniques in critically ill patients: a systematic review and meta-analysis of randomized controlled trials.Frontiers in medicine · 2026Pooled it
- To guide or not to guide percutaneous dilational tracheostomy? broncoscope, ultrasound or nothing?Critical care (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveThis study aimed to investigate the clinical efficacy and safety of ultrasound localization with fiberoptic bronchoscopy-guided percutaneous tracheostomy (US-B PDT) in the intensive care unit (ICU) setting.
methodsA retrospective analysis was conducted on 122 patients who underwent tracheostomy between August 2016 and December 2024 at the Department of Critical Care Medicine, Beijing Electric Power Hospital. Based on the surgical technique employed, patients were divided into two groups: the ultrasound localization and fiberoptic bronchoscopy-guided percutaneous dilatational tracheostomy group (US-B PDT group, n = 62) and the conventional percutaneous dilatational tracheostomy group (PDT group, n = 60). Surgical parameters and intraoperative and postoperative complications were compared between the two groups.
resultsPatients in the US-B PDT group demonstrated statistically significant improvements in several parameters compared to the PDT group, including shorter surgical duration (8.30 ± 0.51 vs. 10.42 ± 1.29 min, respectively), reduced intraoperative blood loss (9.91 ± 0.97 vs. 13.92 ± 0.82 ml, respectively), lower tracheal tube cuff leakage rate (0% vs. 13.3%, respectively), higher first-attempt intubation success rate (96.8% vs. 90.2%, respectively), and decreased sputum overflow rate at the tracheostomy site (3.2% vs. 18.3%, respectively), with p-values < 0.05 for all comparisons. Additionally, the incidence of complications in patients of the US-B PDT group (9.7%) was significantly lower than that in the PDT group (45%) (P < 0.05). Notably, no cases of damage to the posterior tracheal wall or tracheoesophageal fistula were observed in either group.
conclusionThe use of US-B PDT significantly shortened surgical duration, reduced intraoperative blood loss, lowering tracheal tube cuff leakage, enhancing first-attempt intubation success rate, and preventing complications such as posterior tracheal wall injury and tracheoesophageal fistula, ensuring superior safety. These findings highlight the safety and efficacy of this surgical approach for widespread use in ICUs equipped with the necessary facilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.